Concepedia

Nicolas Widmer

NW

Statistics

Publications

39

Citations

2.4K

H-Index

27

Active since

2004

Affiliations

University of Lausanne(Current)

University Hospital of Lausanne

University of Geneva

Pharmacy of the Eastern Vaud Hospitals

University Hospital of Geneva

Nicolas Widmer is an author at University of Lausanne specializing in pharmacology, pharmacy, and pharmacokinetics.

ORCID

Publications per year

2004–2023

39

Publications

39

Towards a new combination therapy for tuberculosis with next generation benzothiazinones

Vadim Makarov, Benoît Lechartier, Ming Zhang et al. · EMBO Molecular Medicine · 2014 · 385 citations · Full text

, , +13

Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry

Amina Haouala, Boris Zanolari, Bertrand Rochat et al. · Journal of Chromatography B · 2009 · 202 citations

, , +16

Population pharmacokinetics of imatinib and the role of α<sub>1</sub>‐acid glycoprotein

Nicolas Widmer, Laurent A. Décosterd, Chantal Csajka et al. · British Journal of Clinical Pharmacology · 2006 · 193 citations · Full text

, , +13

Relationship of imatinib-free plasma levels and target genotype with efficacy and tolerability

Nicolas Widmer, Laurent A. Décosterd, Serge Leyvraz et al. · British Journal of Cancer · 2008 · 126 citations · Full text

, , +14

Multiplex Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification in Human Plasma of Fluconazole, Itraconazole, Hydroxyitraconazole, Posaconazole, Voriconazole, Voriconazole- <i>N</i> -Oxide, Anidulafungin, and Caspofungin

Laurent A. Décosterd, Bertrand Rochat, Benoît Pesse et al. · Antimicrobial Agents and Chemotherapy · 2010 · 121 citations · Full text

, , +15

1–5 of 39